Physician profile
Leila M Khazaeni
NPI 1316979917
$9,052.74
in general payments reported to CMS, 2019-2025
4 companies · $2,250 in 2025
The $2,250 reported for 2025 was more than what 93% of Pediatric Ophthalmology and Strabismus Specialist providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $989 · 2021: $1,101 · 2022: $1,350 · 2023: $1,153 · 2024: $1,500 · 2025: $2,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,900 · Education: $3.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,900.00 |
| Education | $3.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $8,985.00 | 2019-2025 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.92 | 2019 | |
| Travere Therapeutics, INC. | $4.02 | 2021-2023 | Cholbam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leila Khazaeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.